Orion is a globally operating Finnish pharmaceutical company – a builder of well-being.

The company develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. They believe that health and well-being create the foundation for a good life and society. Orion is continuously developing new drugs and treatment methods. The core therapy areas of their pharmaceutical R&D are oncology and pain.

Orion collaborates closely with healthcare professionals and lead global research institutions and pharmaceutical companies. One key initiative is a pharmaceutical research ecosystem. This four-year ecosystem project that begun in March 2023, led by Orion, aims to reduce the time needed to research and develop new, more accurate and safer innovative medicines by using artificial intelligence and enhancing data processing and analysis.

Discover more about Orion at FH23!